氯尼达明,CAS 登记号 50264-69-2,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 氯尼达明 的 CAS 号:50264-69-2,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
lonidamine · CAS 50264-69-2 · C15H10Cl2N2O2. UNII U78804BIDR. Melting Point: 207.
| CAS Registry Number | 50264-69-2 |
|---|---|
| PubChem CID | 39562 |
| Molecular formula | C15H10Cl2N2O2 |
| IUPAC name | 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid |
| UNII (FDA) | U78804BIDR |
| Molecular Weight | 321.2 |
|---|---|
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 320.0119330 |
| Monoisotopic Mass | 320.0119330 |
| Topological Polar Surface Area | 55.1 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Melting Point | 207 |
|---|
| Reported hazard statements | H302 (100%), H351 (92.9%), H360 (92.9%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H351 (92.9%): Suspected of causing cancer [Warning Carcinogenicity]
lonidamine; 50264-69-2; 1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid; Diclondazolic acid; Doridamina; DICA; Lonidamina; Lonidaminum; AF 1890; 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid; 1-(2,4-Dichlorbenzyl)-indazole-3-carboxylic acid; DTXSID5020782; 1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid; NSC-741419; NSC-758419; U78804BIDR
CAS 50264-69-2; molecular formula C15H10Cl2N2O2; molecular weight — g/mol.
lonidamine, 50264-69-2, 1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid, Diclondazolic acid, Doridamina, DICA.
Hazard statements reported: H302, H351, H360.
Melting Point: 207.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.